Curis, Inc. (CRIS) a small cap cancer research biotech has rallied above the declining trendline, broke out of a head and shoulders bottom and closed over 200 MA on a big increase in volume. CRIS has all the makings of a top stock.
I try using the technical analysis skills I have learned from the top stock picking services. When I find a stock that shows the technical chart patterns I like to share it. Usually almost all of the stocks I buy are from Jason Bond or Microcap Millionaires.
You can read my reviews here:
– Robert Walsh